OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients	Euglenozoa Infections, Infections, Skin and Connective Tissue Diseases, cutaneous leishmaniasis, leishmaniasis, parasitic infectious disease, parasitic skin disorder, protozoa infectious disease, skin disorder, skin disorder caused by infection, vector-borne disease	Recruiting	Not stated	2024-07-23		NCT06514560

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Alert Hospital, Ethiopia	2
Armauer Hansen Research Institute, Ethiopia	9
Institute of Tropical Medicine, Belgium	29
The Netherlands Cancer Institute	113
Uppsala University	156

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Africa Leprosy, Tuberculosis, Rehabilitation and Training (ALERT) Hospital	Addis Ababa	Ethiopia	1